Evaluation of the clinical and cost effectiveness of four continuing Sixth Community Pharmacy Agreement (6CPA) MMA programs

Evaluation of the clinical and cost effectiveness of four continuing Sixth Community Pharmacy Agreement (6CPA) MMA programs

The Department of Health engaged HealthConsult to undertake an evaluation to determine the clinical/cost-effectiveness of the Homes Medicines Review (HMR); Residential Medication Management Review (RMMR); MedsCheck; and Diabetes MedsCheck programs.  The project included conducting a systematic review and to identify evidence to inform the comparative clinical and cost-effectiveness of the programs and like programs internationally.  In addition, the project involved analysing available utilisation data since the commencement under earlier Community Pharmacy Agreements.   The evaluations were completed in March 2017 and were considered by the Medical Services Advisory Committee (MSAC) in April 2017.